These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7773641)

  • 21. [Activation mechanisms, biological role and inhibitors of metalloproteases in the extracellular matrix].
    Gacko M
    Postepy Hig Med Dosw; 2001; 55(2):303-18. PubMed ID: 11468976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal transplant fibrosis correlates with intragraft expression of tissue inhibitor of metalloproteinase messenger RNA.
    Nicholson ML; Waller JR; Bicknell GR
    Br J Surg; 2002 Jul; 89(7):933-7. PubMed ID: 12081746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sirolimus ameliorates the enhanced expression of metalloproteinases in a rat model of autosomal dominant polycystic kidney disease.
    Berthier CC; Wahl PR; Le Hir M; Marti HP; Wagner U; Rehrauer H; Wüthrich RP; Serra AL
    Nephrol Dial Transplant; 2008 Mar; 23(3):880-9. PubMed ID: 18042615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal expression of extracellular matrix metalloproteinases and tissue plasminogen activator in the development of collateral vessels in the canine model of coronary occlusion.
    Tyagi SC; Kumar S; Cassatt S; Parker JL
    Can J Physiol Pharmacol; 1996 Aug; 74(8):983-95. PubMed ID: 8960389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection and localization of mRNAs encoding matrix metalloproteinases and their tissue inhibitor in human breast pathology.
    Polette M; Clavel C; Cockett M; Girod de Bentzmann S; Murphy G; Birembaut P
    Invasion Metastasis; 1993; 13(1):31-7. PubMed ID: 8407209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas.
    Kossakowska AE; Urbanski SJ; Watson A; Hayden LJ; Edwards DR
    Oncol Res; 1993; 5(1):19-28. PubMed ID: 8369572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of matrix metalloproteinases in tumor cells].
    Seiki M
    Gan To Kagaku Ryoho; 1993 Feb; 20(3):387-92. PubMed ID: 8439185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts.
    Di Girolamo N; Lloyd A; McCluskey P; Filipic M; Wakefield D
    Am J Pathol; 1997 Feb; 150(2):653-66. PubMed ID: 9033278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of matrix metalloproteinases during extracellular matrix turnover.
    Corcoran ML; Kleiner DE; Stetler-Stevenson WG
    Adv Exp Med Biol; 1995; 385():151-9; discussion 179-84. PubMed ID: 8571826
    [No Abstract]   [Full Text] [Related]  

  • 30. Analysis of the TIMP-1/FIB-CL complex.
    Bodden MK; Windsor LJ; Caterina NC; Yermovsky A; Birkedal-Hansen B; Galazka G; Engler JA; Birkedal-Hansen H
    Ann N Y Acad Sci; 1994 Sep; 732():84-95. PubMed ID: 7978854
    [No Abstract]   [Full Text] [Related]  

  • 31. Literature on vertebrate matrix metalloproteinases and their tissue inhibitors.
    Woessner JF
    Matrix Suppl; 1992; 1():425-501. PubMed ID: 1480084
    [No Abstract]   [Full Text] [Related]  

  • 32. Nomenclature and glossary of the matrix metalloproteinases.
    Nagase H; Barrett AJ; Woessner JF
    Matrix Suppl; 1992; 1():421-4. PubMed ID: 1480083
    [No Abstract]   [Full Text] [Related]  

  • 33. [Adult nephritis models; pathogenesis of nephritogenoside nephritis --its relationship with the immune complex mechanism].
    Shibata S
    Arerugi; 1988 Dec; 37(12):1123-9. PubMed ID: 3073718
    [No Abstract]   [Full Text] [Related]  

  • 34. Post-translational processing and secretion of procollagen in fibroblasts.
    Olsen BR; Berg RA
    Symp Soc Exp Biol; 1979; 33():57-78. PubMed ID: 524274
    [No Abstract]   [Full Text] [Related]  

  • 35. Structural biochemistry and activation of matrix metalloproteases.
    Kleiner DE; Stetler-Stevenson WG
    Curr Opin Cell Biol; 1993 Oct; 5(5):891-7. PubMed ID: 8240832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. From proteins to protein interacting drugs.
    Richards B
    J Pharm Pharmacol; 1992 Feb; 44 Suppl 1():172-7. PubMed ID: 1348279
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical importance of metalloproteinases and their inhibitors.
    Krane SM
    Ann N Y Acad Sci; 1994 Sep; 732():1-10. PubMed ID: 7978783
    [No Abstract]   [Full Text] [Related]  

  • 38. Tissue inhibitors of metalloproteinases: role in tumor progression.
    De Clerck YA; Alvarez O; Shimada H; Taylor SM; Langley KE
    Contrib Nephrol; 1994; 107():108-15. PubMed ID: 8004956
    [No Abstract]   [Full Text] [Related]  

  • 39. Interaction of matrix metalloproteinases with serine protease inhibitors. New potential roles for matrix metalloproteinase inhibitors.
    Mallya SK; Hall JE; Lee HM; Roemer EJ; Simon SR; Golub LM
    Ann N Y Acad Sci; 1994 Sep; 732():303-14. PubMed ID: 7978799
    [No Abstract]   [Full Text] [Related]  

  • 40. Is liver fibrosis reversible?
    Benyon RC; Iredale JP
    Gut; 2000 Apr; 46(4):443-6. PubMed ID: 10716665
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.